PL2247285T3 - Komórkowy środek terapeutyczny na nietrzymanie moczu zawierający komórki macierzyste pochodzące z doczesnej - Google Patents
Komórkowy środek terapeutyczny na nietrzymanie moczu zawierający komórki macierzyste pochodzące z doczesnejInfo
- Publication number
- PL2247285T3 PL2247285T3 PL08854636T PL08854636T PL2247285T3 PL 2247285 T3 PL2247285 T3 PL 2247285T3 PL 08854636 T PL08854636 T PL 08854636T PL 08854636 T PL08854636 T PL 08854636T PL 2247285 T3 PL2247285 T3 PL 2247285T3
- Authority
- PL
- Poland
- Prior art keywords
- decidua
- incontinence
- urine
- stem cells
- therapeutic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070124010 | 2007-11-30 | ||
EP08854636.1A EP2247285B1 (en) | 2007-11-30 | 2008-12-01 | Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua |
PCT/KR2008/007094 WO2009069991A2 (en) | 2007-11-30 | 2008-12-01 | Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2247285T3 true PL2247285T3 (pl) | 2014-11-28 |
Family
ID=40679167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08854636T PL2247285T3 (pl) | 2007-11-30 | 2008-12-01 | Komórkowy środek terapeutyczny na nietrzymanie moczu zawierający komórki macierzyste pochodzące z doczesnej |
Country Status (11)
Country | Link |
---|---|
US (2) | US20110059052A1 (pl) |
EP (1) | EP2247285B1 (pl) |
JP (1) | JP5280451B2 (pl) |
KR (1) | KR101046188B1 (pl) |
CN (1) | CN101801352B (pl) |
CA (1) | CA2692765C (pl) |
ES (1) | ES2478678T3 (pl) |
MX (1) | MX2010000394A (pl) |
PL (1) | PL2247285T3 (pl) |
PT (1) | PT2247285E (pl) |
WO (1) | WO2009069991A2 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4953335B2 (ja) * | 2009-10-06 | 2012-06-13 | 国立大学法人名古屋大学 | 脂肪組織由来間葉系幹細胞を含有する、***不全又は尿意障害用の細胞製剤 |
KR20110095218A (ko) * | 2010-02-18 | 2011-08-24 | 주식회사 강스템홀딩스 | PI3K/AKT/GSK3 경로를 통해 성체줄기세포의 증식, 다분화능 및 재프로그래밍을 촉진하는 CD49f |
US20140050705A1 (en) | 2011-02-25 | 2014-02-20 | Kyungpook National University Hospital | Agent for treating urinary incontinence including stem cells derived from amniotic fluid |
KR101289834B1 (ko) * | 2011-02-25 | 2013-07-24 | 경북대학교병원 | 양수 유래 줄기세포를 함유하는 요실금 치료제 |
JP6607675B2 (ja) * | 2011-07-06 | 2019-11-20 | セル セラピー リミテッド | 中胚葉系列の前駆細胞 |
KR101423659B1 (ko) * | 2011-12-27 | 2014-07-28 | 경북대학교병원 | 초기 분화된 양수 줄기세포를 포함하는 요실금 치료제 |
WO2014040030A1 (en) * | 2012-09-10 | 2014-03-13 | Wake Forest University Health Sciences | Urine stem cells for skeletal muscle generation and uses thereof |
ES2827849B2 (es) * | 2019-11-22 | 2022-07-04 | Fundacion Para La Investig Biomedica Del Hospital 12 De Octubre | Celulas madre de la decidua parietalis de la placenta para su uso en la incontinencia urinaria de esfuerzo cronica |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5516532A (en) * | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
US5654381A (en) * | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
CA2400485C (en) * | 2000-02-26 | 2014-04-29 | Artecel Sciences, Inc. | Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
EP2336300B1 (en) * | 2001-02-14 | 2015-07-08 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
JP4680483B2 (ja) * | 2001-02-23 | 2011-05-11 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法 |
US7651684B2 (en) * | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
JP3934539B2 (ja) * | 2001-12-12 | 2007-06-20 | 独立行政法人科学技術振興機構 | 胎盤等由来の成体又は生後組織の前駆細胞 |
WO2003089619A2 (en) * | 2002-04-19 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Placental derived stem cells and uses thereof |
DK1599575T3 (da) * | 2003-02-20 | 2012-01-16 | Cytori Therapeutics Inc | Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af kardiovaskulære tilstande |
CA2563518C (en) * | 2004-04-23 | 2014-09-02 | Bioe, Inc. | Multi-lineage progenitor cells |
KR100747637B1 (ko) | 2004-11-24 | 2007-08-08 | 전진현 | 포유류 배아 및 줄기세포의 미분화 상태 유지 오씨티-4 유전자 발현 억제용 이중나선 알엔에이 |
KR100745895B1 (ko) | 2004-12-14 | 2007-08-02 | 한국생명공학연구원 | 인간 배아줄기세포에 특이적인 단일클론항체 |
KR100679642B1 (ko) * | 2005-11-16 | 2007-02-06 | 주식회사 알앤엘바이오 | 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제 |
EP1845154A1 (en) * | 2006-04-12 | 2007-10-17 | RNL Bio Co., Ltd. | Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same |
KR100871984B1 (ko) | 2006-04-12 | 2008-12-05 | 주식회사 알앤엘바이오 | 태반 조직 유래 다능성 줄기세포 및 이를 함유하는세포치료제 |
CN101473030A (zh) | 2006-06-15 | 2009-07-01 | Rnl生物技术株式会社 | 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物 |
KR100773460B1 (ko) | 2006-09-22 | 2007-11-06 | 노영도 | 방진 및 방독 마스크 |
CA2679834A1 (en) * | 2007-03-01 | 2008-09-12 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of endometrial/menstrual cells |
KR101425653B1 (ko) | 2007-05-02 | 2014-08-05 | 라정찬 | 인간 지방조직 유래 다분화능 줄기세포 및 모낭세포를함유하는 세포치료제 |
KR20080103637A (ko) | 2007-05-25 | 2008-11-28 | 주식회사 알앤엘바이오 | 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물 |
US8455251B2 (en) * | 2007-11-09 | 2013-06-04 | Rnl Bio Co., Ltd. | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
-
2008
- 2008-12-01 PT PT88546361T patent/PT2247285E/pt unknown
- 2008-12-01 MX MX2010000394A patent/MX2010000394A/es active IP Right Grant
- 2008-12-01 KR KR1020080120535A patent/KR101046188B1/ko active IP Right Grant
- 2008-12-01 JP JP2010523967A patent/JP5280451B2/ja not_active Expired - Fee Related
- 2008-12-01 WO PCT/KR2008/007094 patent/WO2009069991A2/en active Application Filing
- 2008-12-01 CN CN2008800242499A patent/CN101801352B/zh not_active Expired - Fee Related
- 2008-12-01 US US12/668,592 patent/US20110059052A1/en not_active Abandoned
- 2008-12-01 PL PL08854636T patent/PL2247285T3/pl unknown
- 2008-12-01 CA CA2692765A patent/CA2692765C/en not_active Expired - Fee Related
- 2008-12-01 ES ES08854636.1T patent/ES2478678T3/es active Active
- 2008-12-01 EP EP08854636.1A patent/EP2247285B1/en not_active Not-in-force
-
2013
- 2013-01-10 US US13/738,479 patent/US9211306B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2247285B1 (en) | 2014-06-11 |
ES2478678T3 (es) | 2014-07-22 |
EP2247285A2 (en) | 2010-11-10 |
CA2692765A1 (en) | 2009-06-04 |
CN101801352B (zh) | 2013-04-03 |
JP2010538059A (ja) | 2010-12-09 |
US9211306B2 (en) | 2015-12-15 |
MX2010000394A (es) | 2010-05-13 |
CN101801352A (zh) | 2010-08-11 |
PT2247285E (pt) | 2014-07-25 |
JP5280451B2 (ja) | 2013-09-04 |
US20130189232A1 (en) | 2013-07-25 |
KR20090056925A (ko) | 2009-06-03 |
KR101046188B1 (ko) | 2011-07-04 |
US20110059052A1 (en) | 2011-03-10 |
WO2009069991A2 (en) | 2009-06-04 |
CA2692765C (en) | 2015-09-22 |
WO2009069991A3 (en) | 2009-08-06 |
EP2247285A4 (en) | 2012-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2247285T3 (pl) | Komórkowy środek terapeutyczny na nietrzymanie moczu zawierający komórki macierzyste pochodzące z doczesnej | |
IL233377A (en) | A matrix containing placental stem cells for the treatment of inflammatory diseases | |
EP2146632A4 (en) | COMPOSITIONS AND METHODS FOR CELLULAR IMAGE PRESENTATION AND THERAPY | |
GB2446847B (en) | Location of Basestation | |
IL208383A0 (en) | Action times for handover of mobile stations | |
EP2007874A4 (en) | PROPAGATION OF PRIMARY CELLS | |
HK1170258A1 (en) | Expansion of nk cells nk | |
ZA201007762B (en) | Applicator for self-expanding intravaginal urinary incontinence devices | |
IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
EP1879578A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | |
SI2292231T1 (sl) | Terapevtsko sredstvo za stenozo spinalnega kanala | |
GB0724904D0 (en) | Improved soft handover for cellular radio systems | |
ZA201000278B (en) | Human umbilical tissue-derived cell compositions for the treatment of incontinence | |
EP2434983A4 (en) | CORRECTION OF URINARY INCONTINENCE DUE TO VOLTAGE | |
IL194826A0 (en) | Compositions and methods for cellular imaging and therapy | |
EP1917348A4 (en) | ISOLATION OF MULTIPLE LINE STEM CELLS | |
EP2003978A4 (en) | ALLOGENIC CELL THERAPY TO TREAT OPPORTUNISTIC INFECTION | |
EP2180318A4 (en) | DIAGNOSTIC AGENT FOR URINARY CAT PROTEIN | |
GB0723504D0 (en) | Treatment of eukaryotic cellular biomass | |
EP2418222A4 (en) | THERAPEUTIC AGENT FOR DISEASES IN WHICH A NEOPLASTIC PROLIFERATION OF PLASMOCYTES OCCURS | |
EP2412705A4 (en) | NEW THERAPEUTIC AGENT FOR COGNITIVE DEFICIT | |
ZA200905681B (en) | Therapeutic agent for urinary excretion disorder | |
EP1725247A4 (en) | POLYPHENOLS AS AN INTRAVESICAL AGENT FOR THE PREVENTION OF TRANSITIONAL CELLULAR TUMORAL IMPLANTATION | |
GB2480406B (en) | Location of basestation | |
HU0400289D0 (en) | Composition for treatment of urine incontinence |